Immuron Provides Update on First Half of FY20 Results
Immuron Limited - American Depositary Shares (IMRN)
US:NASDAQ Investor Relations:
immuron.com/investor-centre/business-overview
Company Research
Source: GlobeNewswire
Key Highlights: Strong continued growth of Travelan® sales reported in all marketsGlobal sales reached USD $1.1 million (AUD $1.68 million) for first half FY 2020 up 55% from first half FY 2019North American Travelan® sales up by 98% YoY in the first half of FY20IMM-124E/Travelan® US registration strategy - Pre-IND meeting completed with the U.S. FDAUSD $3.7 (AUD $5.5) million non-dilutive funding approved by US Department of Defense to develop and clinically evaluate a new therapeutic targeting Campylobacter and ETECFDA strategy updated for clinical development of IMM-529U.S. Department of Defense Travelan® Shigellosis animal study results reportedThree new Shigella drug product candidates commence preclinical evaluation by WRAIRResearch and development tax concession refund paid MELBOURNE, Australia, March 03, 2020 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics
Show less
Read more
Impact Snapshot
Event Time:
IMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMRN alerts
High impacting Immuron Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMRN
News
- Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventGlobeNewswire
- Immuron Limited to Present at November 21st Virtual Investor Summit Microcap EventAccesswire
- Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceGlobeNewswire
- Immuron Travelan® continued strong sales growthGlobeNewswire
- NMRC Reports Results for Campylobacter Controlled Human Infection Model StudyGlobeNewswire
IMRN
Sec Filings
- 11/18/24 - Form 6-K
- 11/14/24 - Form 6-K
- 10/29/24 - Form 6-K
- IMRN's page on the SEC website